Rene Marc Huberdeau, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: Clark-holder Clinic, P.a., 303 Smith Street, Lagrange, GA 30240 Phone: 706-882-8831 Fax: 706-812-4091 |
Dr. Megan Lisset Jimenez, DO Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 1805 Vernon Rd Ste B, Lagrange, GA 30240 Phone: 706-884-2691 Fax: 706-845-7314 |
Dr. Robert R Comerford, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1805 Vernon Rd, Suite B, Lagrange, GA 30240 Phone: 706-884-2691 Fax: 706-845-7314 |
Dr. Daniel K Guy, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1805 Vernon Rd, Suite B, Lagrange, GA 30240 Phone: 706-884-2691 Fax: 706-845-7314 |
James G Killebrew Jr., M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: Clark-holder Clinic, P.a., 303 Smith Street, Lagrange, GA 30240 Phone: 706-882-8831 Fax: 706-812-4091 |
Dr. James F Bruce Jr., MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1805 Vernon Rd, Suite B, Lagrange, GA 30240 Phone: 706-884-2691 Fax: 706-845-7314 |
Dr. Brian M Terry, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1805 Vernon Rd, Suite B, Lagrange, GA 30240 Phone: 706-884-2691 Fax: 706-845-7314 |
News Archive
One of the defining elements of the 2016 election cycle was its focus on immigration. On both sides of the partisan divide, immigration figured heavily into candidates' talking points and served as a key determinant of voting behavior.
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has opened a Customer Care office in Shanghai to service biopharmaceutical researchers in China and Taiwan who are using Perceptive's technology solutions.
A subpopulation of the immune cells targeted by HIV may play an important role in controlling viral loads after initial infection, potentially helping to determine how quickly infection will progress. In the February 29 issue of Science Translational Medicine, a team of researchers from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard describe finding a population of HIV-specific CD4 T cells - cells traditionally thought to direct and support activities of other immune cells - that can directly kill HIV-infected cells.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.
› Verified 1 days ago